China · Delayed Price · Currency is CNY Aurisco Pharmaceutical Statistics
Total Valuation
SHA:605116 has a market cap or net worth of CNY 11.02 billion. The enterprise value is 11.01 billion.
| Market Cap | 11.02B |
| Enterprise Value | 11.01B |
Important Dates
The last earnings date was Friday, April 17, 2026.
| Earnings Date | Apr 17, 2026 |
| Ex-Dividend Date | Jun 20, 2025 |
Share Statistics
SHA:605116 has 406.18 million shares outstanding. The number of shares has increased by 2.44% in one year.
| Current Share Class | 406.18M |
| Shares Outstanding | 406.18M |
| Shares Change (YoY) | +2.44% |
| Shares Change (QoQ) | +1.29% |
| Owned by Insiders (%) | 73.99% |
| Owned by Institutions (%) | 2.82% |
| Float | 92.32M |
Valuation Ratios
The trailing PE ratio is 24.65 and the forward PE ratio is 19.94.
| PE Ratio | 24.65 |
| Forward PE | 19.94 |
| PS Ratio | 6.49 |
| PB Ratio | 4.15 |
| P/TBV Ratio | 4.41 |
| P/FCF Ratio | 154.23 |
| P/OCF Ratio | 26.13 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.18, with an EV/FCF ratio of 154.22.
| EV / Earnings | 24.52 |
| EV / Sales | 6.49 |
| EV / EBITDA | 16.18 |
| EV / EBIT | 19.85 |
| EV / FCF | 154.22 |
Financial Position
The company has a current ratio of 3.95, with a Debt / Equity ratio of 0.36.
| Current Ratio | 3.95 |
| Quick Ratio | 2.67 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 1.40 |
| Debt / FCF | 13.34 |
| Interest Coverage | 15.98 |
Financial Efficiency
Return on equity (ROE) is 18.01% and return on invested capital (ROIC) is 18.68%.
| Return on Equity (ROE) | 18.01% |
| Return on Assets (ROA) | 8.56% |
| Return on Invested Capital (ROIC) | 18.68% |
| Return on Capital Employed (ROCE) | 14.99% |
| Weighted Average Cost of Capital (WACC) | 3.76% |
| Revenue Per Employee | 951,501 |
| Profits Per Employee | 251,799 |
| Employee Count | 1,784 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.11 |
Taxes
In the past 12 months, SHA:605116 has paid 69.09 million in taxes.
| Income Tax | 69.09M |
| Effective Tax Rate | 13.33% |
Stock Price Statistics
The stock price has increased by +26.38% in the last 52 weeks. The beta is -0.08, so SHA:605116's price volatility has been lower than the market average.
| Beta (5Y) | -0.08 |
| 52-Week Price Change | +26.38% |
| 50-Day Moving Average | 26.77 |
| 200-Day Moving Average | 24.53 |
| Relative Strength Index (RSI) | 44.73 |
| Average Volume (20 Days) | 9,772,189 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:605116 had revenue of CNY 1.70 billion and earned 449.21 million in profits. Earnings per share was 1.10.
| Revenue | 1.70B |
| Gross Profit | 1.01B |
| Operating Income | 554.85M |
| Pretax Income | 518.30M |
| Net Income | 449.21M |
| EBITDA | 674.15M |
| EBIT | 554.85M |
| Earnings Per Share (EPS) | 1.10 |
Balance Sheet
The company has 953.90 million in cash and 953.10 million in debt, with a net cash position of 798,643 or 0.00 per share.
| Cash & Cash Equivalents | 953.90M |
| Total Debt | 953.10M |
| Net Cash | 798,643 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 2.66B |
| Book Value Per Share | 6.90 |
| Working Capital | 1.54B |
Cash Flow
In the last 12 months, operating cash flow was 421.50 million and capital expenditures -350.07 million, giving a free cash flow of 71.42 million.
| Operating Cash Flow | 421.50M |
| Capital Expenditures | -350.07M |
| Depreciation & Amortization | 119.30M |
| Net Borrowing | 6.00M |
| Free Cash Flow | 71.42M |
| FCF Per Share | 0.18 |
Margins
Gross margin is 59.67%, with operating and profit margins of 32.69% and 26.46%.
| Gross Margin | 59.67% |
| Operating Margin | 32.69% |
| Pretax Margin | 30.53% |
| Profit Margin | 26.46% |
| EBITDA Margin | 39.71% |
| EBIT Margin | 32.69% |
| FCF Margin | 4.21% |
Dividends & Yields
This stock pays an annual dividend of 0.29, which amounts to a dividend yield of 1.05%.
| Dividend Per Share | 0.29 |
| Dividend Yield | 1.05% |
| Dividend Growth (YoY) | 31.82% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 27.63% |
| Buyback Yield | -2.44% |
| Shareholder Yield | -1.39% |
| Earnings Yield | 4.08% |
| FCF Yield | 0.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |